Sökning: onr:"swepub:oai:gup.ub.gu.se/60049" > Budesonide/Formoter...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 02916naa a2200325 4500 | |
001 | oai:gup.ub.gu.se/60049 | |
003 | SwePub | |
008 | 240910s2005 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/600492 URI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a O'Byrne P, M.4 aut |
245 | 1 0 | a Budesonide/Formoterol combination therapy as both maintenance and reliever medication in asthma |
264 | 1 | c 2005 |
520 | a Asthma control is improved by combining inhaled corticosteroids with long-acting beta(2)-agonists. However, fluctuating asthma control still occurs. We hypothesized that in patients receiving low maintenance dose budesonide/formoterol (bud/form), replacing short-acting beta(2)-agonist (SABA) reliever with as-needed bud/form would provide rapid symptom relief and simultaneous adjustment in antiinflammatory therapy, thereby reducing exacerbations. In this double-blind, randomized, parallel-group study, 2,760 patients with asthma aged 4-80 years (FEV(1) 60-100% predicted) received either terbutaline 0.4 mg as SABA with bud/form 80/4.5 mug twice a day (bud/form + SABA) or bud 320 mug twice a day (bud + SABA) or bud/form 80/4.5 mug twice a day with 80/4.5 mug as-needed (bud/form maintenance + relief). Children used a once-nocte maintenance dose. Bud/form maintenance + relief prolonged time to first severe exacerbation (p < 0.001; primary endpoint), resulting in a 45-47% lower exacerbation risk versus bud/form + SABA (hazard ratio, 0.55; 95% confidence interval, 0.44, 0.67) or bud + SABA (hazard ratio, 0.53; 95% confidence interval 0.43, 0.65). Bud/form maintenance + relief also prolonged the time to the first, second, and third exacerbation requiring medical intervention (p < 0.001), reduced severe exacerbation rate, and improved symptoms, awakenings, and lung function compared with both fixed dosing regimens. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Lungmedicin och allergi0 (SwePub)302192 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Respiratory Medicine and Allergy0 (SwePub)302192 hsv//eng |
700 | 1 | a Bisgaard, H.4 aut |
700 | 1 | a Godard, P. P.4 aut |
700 | 1 | a Pistolesi, M.4 aut |
700 | 1 | a Palmqvist, Mona,d 1957u Gothenburg University,Göteborgs universitet,Institutionen för invärtesmedicin, Avdelningen för lungmedicin och allergologi,Institute of Internal Medicine, Dept of Respiratory Medicine/Allergology4 aut0 (Swepub:gu)xpamon |
700 | 1 | a Zhu, Y.4 aut |
700 | 1 | a Ekström, T.4 aut |
700 | 1 | a Bateman, E. D.4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för invärtesmedicin, Avdelningen för lungmedicin och allergologi4 org |
773 | 0 | t Am J Respir Crit Care Medg 171:2, s. 129-36q 171:2<129-36 |
856 | 4 8 | u https://gup.ub.gu.se/publication/60049 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy